Do patients with subclinical rejection have higher rates of graft loss than AMR-free matched controls?
What is the recommendation regarding the active use of marijuana in a patient with a history of substance abuse?
The incidence of cardiovascular disease in kidney transplant recipients is nearly twice that in the general population.
Find out how efficient donor organ allocation can optimize transplant outcomes.
Find strategies to minimize this emerging threat in the vulnerable population of solid organ transplant recipients.
Is there any evidence for use of parenteral ganciclovir for prophylaxis against cytomegalovirus (CMV) infection in high-risk patients, especially when the oral formulation is not available?
Potential donors with persistent or intermittent glomerular hematuria may need a closer look before getting a green light for donation.
Although I am a physician (in general primary care), I am also a transplant patient. I had a previous transplant from 1983 to 1995. I now have a 5-year-old second kidney transplant, which seems to be suffering chronic rejection.
Transplantation of cultured human islet allografts results in reproducible insulin independence in all subjects under this regimen, comparable to that of the Edmonton protocol.
The paradigm has shifted from an emphasis on short-term immunologic to long-term nonimmunologic outcomes as the ultimate measure of success in kidney transplantation.
In this video blog Ron Shapiro, MD discusses emerging data on the proteasome inhibitor bortezomib, a chemotherapeutic agent that targets plasma cells, for treatment of humoral rejection.
How much does it cost to prepare to donate a kidney?
Transplant recipients should be routinely evaluated for CVD risk factors to improve cardiovascular health and extend graft and patient survival.
What are the most common psychological disorders after live kidney donation?
How much does chronic exposure to cigarette smoke impact donor lung status?
September is National Cholesterol Education Month. The NCEP is pleased to present the 2005 National Cholesterol Education Month Kit online.
Recognizing that transplantation of nonhuman live cells presents a risk of introducing infectious diseases into the human population, the Food and Drug Administration's Center for Biologics Evaluation and Research initiated a Xenotransplantation Action Plan.
Early rehospitalization after kidney transplantation is common, but does it predict future outcomes?
In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a new study which suggests that we can continue to explore regimens that involve steroid avoidance after renal transplantation.
Can conversion to sirolimus immunosuppression reduce the recurrence of skin cancer in renal transplant patients? Dr. Ron Shapiro discusses a randomized, controlled study that shows promising results.